$TSNDF Cashflow Statement | Understand Stock

$TSNDF

$0.69 +$0.04 (6.17%) Close

$TSNDF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Operating activities
Net loss from continuing operations
Adjustments to reconcile net loss to net cash provided by operating activities
Non-cash adjustments of inventory
Pennsylvania
Total non-cash adjustments of inventory

Accretion expense
Accretion and accrued interest
Depreciation of property and equipment and amortization of intangible assets
Amortization of operating right-of-use assets
Share-based compensation
Deferred income tax expense recovery
(Gain) loss on fair value of warrants and purchase option derivative
Gain on fair value of derivative liabilities and purchase option derivative assets
Loss (gain) on fair value of derivative liabilities
Unrealized and realized loss on investments
Impairment of goodwill and intangible assets
Impairment of property and equipment and right of use assets
Loss on derecognition of right of use assets and lease termination
(Gain) loss on lease termination and derecognition of finance lease
Release of indemnification asset
Bad debt expense
Bad debt (recovery) expense
Employee Retention Credits recorded in other income
Provision for expected credit loss (recovery)
Loss on extinguishment of debt
Debt modification fees expensed
Debt modification fees
Unrealized and realized foreign exchange (gain) loss
Impairment and other

Changes in operating assets and liabilities
Receivables
Inventory
Accounts payable and accrued liabilities
Operating lease liability
Other liability
Uncertain tax position liabilities
Contingent consideration payable
Corporate income tax payable
Deferred revenue
Income taxes paid and tax related liabilities
Prepaid expense and other current assets
Deposits
Other assets
Accounts payable and accrued liabilities and other payables
Other assets and liabilities

Net cash provided by operating activities - continuing operations
Net cash used in operating activities - discontinued operations
Net cash provided by operating activities
Investing activities
Investment in property and equipment
Investment in note receivable, net of interest received
Investment in intangible assets
Principle payments received on lease receivable
Insurance recovery for property and equipment
Payments made for land contracts
Cash portion of consideration paid in acquisitions, net of cash acquired
Success fees related to ATC and other investment
Cash portion of consideration paid in acquisition
Deposits for business acquisition
Payment for land contracts
Success fees related to Alternative Treatment Center license
Net cash used in investing activities- continuing operations
Net cash provided by (used in) investing activities - discontinued operations
Net cash used in investing activities

Financing activities
Transfer of Employee Retention Credit
Proceeds from loans payable, net of transaction costs
Proceeds from options and warrants exercised
Loan modification fees paid
Loan amendment fee paid and prepayment premium paid
Tax distributions to NJ partners
Capital contributions (paid) received (to) from non-controlling interests
Loan exit fee paid
Capital distributions paid to non-controlling interests
Proceeds from contingent consideration
Payments of contingent consideration
Payments made for financing obligations and finance lease
Repurchases of common shares
Proceeds from private placement, net of share issuance costs
Proceeds from options exercised
Employee retention credit
Net cash provided by (used in) financing activities- continuing operations
Net cash used in financing activities- discontinued operations
Net cash (used in) provided by financing activities

Net increase (decrease) in cash and cash equivalents and restricted cash during the year
Net effects of foreign exchange
Cash and cash equivalents and restricted cash, beginning of the year
Cash and cash equivalents and restricted cash, end of the year
Supplemental disclosure with respect to cash flows
Cash paid (received) for income tax, net
Federal income tax
Total cash paid (received) for income tax, net
Interest paid
Lease termination fee paid
Non-cash transactions
Shares issued- Canopy USA arrangement
Equity and warrant liability issued as consideration for acquisition
Shares issued for liability settlement
Equity and warrant liability issued for acquisitions and non-controlling interest
Change in accured capital expenditures
Equity issued for price protection on contingent consideration
Warrant issued as consideration for services
Promissory note issued as consideration for acquisitions
Debt instrument issued as consideration for acquisitions
Shares issued for legal and liability settlement
Shares issued by Canopy USA arrangement

Comments